References
- FennellyDDose intensity in advanced ovarian cancer: have we answered the question?Clin Cancer Res1995165755829816018
- KobayashiMWoodPAHrusheskyWJCircadian chemotherapy for gynecological and genitourinary cancersChronobiol Int200219123725111962679
- MinkoTDharapSSPakunluRIWangYMolecular targeting of drug delivery systems to cancerCurr Drug Targets20045438940615134222
- DinarvandRSepehriNManoochehriSRouhaniHAtyabiFPolylactide- co-glycolide nanoparticles for controlled delivery of anti-cancer agentsInt J Nanomedicine2011687789521720501
- ChoNChuehPJKimCCaldwellSMorreDMMorreDJMonoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patientsCancer Immunol Immunother200251312112911941450
- LukyanovANElbayoumiTAChakilamARTorchilinVPTumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibodyJ Control Release2004100113514415491817
- DharapSSWangYChandnaPTumor-specific targeting of an anticancer drug delivery system by LHRH peptidePANS2005102361296212967
- HeYZhangLSongCLuteinizing hormone-releasing hormone receptor- mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomesInt J nanomedicine2010569770520957221
- ChenSZhaoXChenJMechanism-based tumor-targeting drug delivery system validation of efficient vitamin receptor-mediated endocytosis and drug releaseBioconjug Chem201021597998720429547
- ZhaoDZhaoXZuYPreparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticlesInt J Nanomedicine2010566967720957218
- SaltanNKutluMHHürDIscanASayRInteraction of cancer cells with magnetic nanoparticles modified by methacrylamido-folic acidInt J Nanomedicine2011647748421468352
- SwansonSDKukowska-LatalloJFPatriAKTargeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancementInt J Banomedicine200832201210
- LiQLiuCZhaoXPreparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cellsInt J Nanomedicine2011639740521499429
- LiXTianXZhangJIn vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxelInt J Nanomedicine201161167118421852896
- XieJShenZLiKCPDanthiNTumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticleInt J Nanomedicine20072347948518019845
- YangWChengYXuTWangXWenL-pTargeting cancer cells with biotin dendrimer conjugatesEur J Med Chem200944286286818550227
- PatilYSadhukhaTMaLPanyamJNanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistanceJ Control Release20091361212919331851
- NaKSelf-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery systemEur J Pharm Sci200318216517312594010
- TaheriADinarvandRAtyabiFTargeted delivery of methotrexate to tumor cells by means of biotin functionalized methotrexate-human serum albumin nanoparticlesJ Biomed Nanotechnol2011 In press
- TaoKAlroyJSahagianGGImagable 4T1 model for the study of late stage breast cancerBMC Cancer2008822818691423
- AslaksonCJMillerFRSelective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumorCancer Res1992152139914051540948
- Russell-jonesMcewanJAccess Pharmaceuticals Australia PTY LTD, assignee. Amplification of biotin-mediated targetingUnited States patent US 200601273106152006
- TaheriAAtyabiFSalman NouriFNanoparticles of conjugated methotrexate-human serum albumin: Preparation and cytotoxicity evaluationsJ Nanomater2011Article ID 768201
- KosasihABowmanBJWigentRJOfnerCMIIICharacterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variablesInt J Pharm20002041–2818911011989
- GreenNCA spectrophotometric assay for avidin and biotin based on binding of dyes by avidinBiochem J19659423C24C
- VredenburgMROjimaIVeithJEffects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistanceJ Natl Cancer Inst200193161234124511504769
- GeranRIGreenbergNHMac DonaldMMSchumacherAMAbbotBJProtocols for screening chemical agents and natural products against animal tumors and other biological systemsCancer Chemo Rep197231103
- TsengCSuWYenKYangKLinFThe use of biotinylated- EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalationBiomaterials200930203476348519345990
- AnhornMGWagnerSKreuterJLangerKBriesenHSpecific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticlesBioconjugate Chem2008191223212333
- WagnerSRothweilerFAnhornMGEnhanced drug targeting by attachment of an anti av integrin antibody to doxorubicin loaded human serum albumin nanoparticlesBiomaterials20103182388239820031203
- ZhangLHouSMaoSWeiDSongXLuYUptake of folate-conjugated albumin nanoparticles to the SKOV3 cellsInt J Pharm20042871–215516215541922
- KratzFAlbumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJ Control Release2008132317118318582981
- KreuterJHekmataraTDreisSVogelTGelperinaSLangerKCovalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brainJ Control Release20071181545817250920
- SteinhauserISpankuchbBStrebhardtKLangerKTrastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cellsBiomaterials200627284975498316757022
- EsmaeiliFDinarvandRGhahremaniMHDocetaxel-albumin conjugates: Preparation, in vitro evaluation and biodistribution studiesJ Pharm Sci20099882718273018972321
- TuanVChuangGKragh-HansenUOtagiriMPharmaceutical strategies utilizing recombinant human serum albuminPharm Res200219556957712069157
- de KoningBAEvan DierenJMLindenbergh-KortleveDJContributions of mucosal immune cells to methotrexate-induced mucositisInt Immunol200618694194916636014